
Natural Capsules Q3 & 9MFY26 Results: Revenue Up, EBITDA Margins Down
Natural Capsules Limited, a leading manufacturer of hard capsules shell, has announced its financial results for the quarter ended December 31, 2025. The company's revenue for the quarter stood at 37.75 Cr, an increase of 2.33 Cr compared to the same period last year. However, EBITDA margins saw a decline of 6.16% due to various factors including a temporary shutdown of the Puducherry unit following regulatory action. The unit is now operational and the delayed shipments have been executed in the current quarter. The company also announced that US trade tariffs impacting their HPMC capsules have been eased, restoring visibility on growth in the US market. For the nine months ended December 31, 2025, the revenue stood at 128.75 Cr, an increase of 2.89 Cr compared to the same period last year. The company's PAT for the nine months stood at 19.69 Cr.
Key Highlights
- Revenue for Q3 FY26 stood at 37.75 Cr, an increase of 2.33 Cr Y-o-Y
- EBITDA margins for Q3 FY26 declined by 6.16%
- US trade tariffs impacting HPMC capsules have been eased
- Puducherry unit is now operational
- Company's PAT for 9MFY26 stood at 19.69 Cr